Pharmacoscintigraphic evaluation of LCZ696 formulations

• Research type

  Research Study

• Full title

  Publication of this data is currently deferred.

• IRAS ID

  269893

• Contact name

  Howard N.E. Stevens

• Contact email

  howard.stevens@bddpharma.com

• Sponsor organisation

  Publication of this data is currently deferred.

• Eudract number

  2019-002831-27

• Duration of Study in the UK

  0 years, 0 months, 31 days

• Research summary

  Publication of this data is currently deferred.

• REC name

  London - Riverside Research Ethics Committee

• REC reference

  19/LO/1342

• Date of REC Opinion

  8 Aug 2019

• REC opinion

  Favourable Opinion